Clotting Genetic Variants, Hormones, and Venous Thrombosis
NCT00094185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2012-12-20
Summary
To identify genetic variants in 12 key blood clotting proteins that may modify the risk of venous thromboembolism in users of hormone replacement therapy.
Conditions
- Cardiovascular Diseases
- Thromboembolism
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Nicholas Smith · University of Washington
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
More Related Trials
-
Genetic Epidemiology of Venous Thromboembolism
NCT00005543 ·Status: COMPLETED
-
Monitoring Trends in Venous Thromboembolism
NCT00063518 ·Status: COMPLETED
-
New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study "FIT GENETIQUE".
NCT02841085 ·Status: COMPLETED
-
Incidence and Outcomes of Venous Thromboembolism
NCT00005351 ·Status: COMPLETED
-
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
NCT01006733 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
NCT00511173 ·Status: COMPLETED ·Phase: PHASE4
-
Epidemiology of Venous Thromboembolism
NCT00041457 ·Status: COMPLETED
-
Risk Factors for Venous Thromboembolism in the Community
NCT00011180 ·Status: COMPLETED
-
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
NCT03521908 ·Status: COMPLETED
-
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
NCT03206372 ·Status: RECRUITING
-
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
NCT00311753 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 ·Status: UNKNOWN
-
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
NCT00927862 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
NCT01357941 ·Status: UNKNOWN
-
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
NCT00634907 ·Status: COMPLETED ·Phase: NA
-
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT03404635 ·Status: COMPLETED
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING
-
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
NCT01264458 ·Status: COMPLETED
-
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
NCT00451412 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
NCT05795062 ·Status: COMPLETED
-
Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode
NCT04920487 ·Status: COMPLETED
-
Medical Assistance for the Procreation and Risk of Thrombosis.
NCT02610608 ·Status: TERMINATED
-
Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women
NCT00745212 ·Status: COMPLETED
-
Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin
NCT05819125 ·Status: TERMINATED
-
Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
NCT01006876 ·Status: COMPLETED ·Phase: PHASE3